🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07543705
Recruiting Observational

Glucose-Level During Endurance Exercise

NCT07543705 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2026-05-05
Last updated
2026-05-11

Condition(s) studied

Glucose Metabolism

Investigational drug(s) / intervention(s)

Standardized military march

Standardized military march: 6 km march carrying 15 kg of equipment. The march will be conducted in uniform in accordance with central military regulations. Participants will be equipped with a continuous glucose monitor an electrocardiography wearable during the march. Before and after the march blood and urine samples will be obtained.

Study summary

As part of the mandatory annual assessment of physical fitness, soldiers are required to complete a standardized military march. A total of 100 healthy volunteer participants will be recruited from soldiers serving at the Bundeswehr Hospital Ulm. During this march, physiological and metabolic parameters will be assessed.

At baseline, anthropometric data and information on medical history, lifestyle, and fitness status will be collected, including a validated questionnaire on physical activity. Blood and urine samples will be obtained to determine routine laboratory and metabolic parameters, and body composition will be assessed using bioelectrical impedance analysis. In addition, selected sensors will be applied to continuously record physiological data.

Participants will then complete a 6 km march carrying 15 kg of equipment. After completion of the march, sensors will be removed and additional blood and urine samples will be collected to evaluate metabolic responses to physical exertion, including catecholamine levels.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * BMI between 18.5 and 30 kg/m\^2 Exclusion Criteria: * Pregnancy or lactation * cardiovascular disease * vegan diet * drug or alcohol abuse * Drug therapy that raises or lowers blood sugar, e.g. steroids, antidiabetics, insulin or influences the autonomic nervous system * No consent to be informed about incidentally discovered pathological findings * Any other (clinical) condition that would endanger participants safety or question scientific success according to the physicians opinion.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bundeswehr Hospital Ulm Ulm Germany Recruiting

More University of Ulm trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07543705 on ClinicalTrials.gov ↗ ← All trials in Germany